Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Attendo ABOSTO:ATT +1.74%64 5-Year Yield-on-Cost % is 0.82 as of Jul. 28, 2026, which is 45% below its 10-year median of 1.50. GuruFocus rates OSTO:ATT with a GF Score™ of 64/100 and a GF Value™ of kr56.49 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Attendo AB ranks worse than 83.03% on this metric.
Attendo AB's yield on cost for the quarter that ended in Mar. 2026 was 0.82.
The historical rank and industry rank for Attendo AB's 5-Year Yield-on-Cost % or its related term are showing as below:
OSTO:ATT'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.61 Med: 1.5 Max: 3.23
Current: 0.82
During the past 13 years, Attendo AB's highest Yield on Cost was 3.23. The lowest was 0.61. And the median was 1.50.
OSTO:ATT's 5-Year Yield-on-Cost % is ranked worse than 83.03% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs OSTO:ATT: 0.82
Attendo AB (OSTO:ATT) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Attendo AB 5-Year Yield-on-Cost % Related Terms
OSTO:ATT vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Attendo AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Attendo AB 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Attendo AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Attendo AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Attendo AB is calculated as
Attendo AB (OSTO:ATT) has a 5-Year Yield-on-Cost % of 0.82 as of Jul. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Attendo AB and its competitors. This is 45% below median its historical median of 1.50. Over the past decade, Attendo AB's 5-Year Yield-on-Cost % has ranged from 0.61 to 3.23. According to the industry distribution chart, Attendo AB ranks #230 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 83%.
Is Attendo AB's 5-Year Yield-on-Cost % too high?
Attendo AB's current 5-Year Yield-on-Cost % of 0.82 is 45% below median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 3.23. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Attendo AB's value of 0.82 is 72% below this industry median. Based on the distribution chart, Attendo AB ranks #230 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Attendo AB has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Attendo AB's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Attendo AB ranks #230 out of 277 companies for 5-Year Yield-on-Cost %. This places Attendo AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Attendo AB's value of 0.82 is 72% below this benchmark. Historically, Attendo AB's own 5-Year Yield-on-Cost % has ranged from 0.61 to 3.23 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 2.93, Attendo AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Attendo AB's current 5-Year Yield-on-Cost % of 0.82 is 72% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Attendo AB and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Attendo AB's current 5-Year Yield-on-Cost % is 0.82, which is 45% below median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attendo AB stock overvalued right now?
Based on GuruFocus' analysis, Attendo AB (OSTO:ATT) is currently considered Significantly Overvalued. The stock's GF Value™ is kr56.49, compared to a current price of kr111.20 — trading 96.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.82, which is 45% below median its 10-year median of 1.50 and 72% below the Healthcare Providers & Services industry median of 2.93. Attendo AB's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Attendo AB (OSTO:ATT), the current 5-Year Yield-on-Cost % is 0.82 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Attendo AB (OSTO:ATT) Overvalued in 2026?
Based on GuruFocus' analysis, Attendo AB stock appears to be overvalued.
The current stock price of kr111.20 is trading 96.8% above its estimated GF Value™ of kr56.49.
GuruFocus considers Attendo AB to be Significantly Overvalued.
Key valuation signals for OSTO:ATT:
5-Year Yield-on-Cost %: 0.82 (45% below median its 10-year median of 1.50)
GF Value™: kr56.49 vs. price of kr111.20 (96.8% above fair value)
Industry Position: 72% below the Healthcare Providers & Services median (#230 of 277)
No single metric tells the full story. See the OSTO:ATT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Attendo AB is a company that is engaged in providing private care and healthcare services in the Nordics. It focuses on offering care for older people, care for people with disabilities, individual and family care, and health care. The company also offers health, medical, and as well as staffing services. Geographically, the group's majority revenue is generated from Finland, it also operates in Scandinavia countries.
64GF Score
Get the complete analysis for OSTO:ATT
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ATT has been successfully added to your 
